Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

Mundipharma (United Kingdom)

mundipharmaresearch.comROR OpenAlex
World rank, all time
#24,545
of 34,923
Rank in United Kingdom
#1,297
of 1,844
Research works
209
◆ 0% vs 2018-21
Citations
6.5k
31.0 per fractional work
Top-10% rate
11.0%
all institutions 10.0%
vs its own fields
1.06×
1.00× is exactly expected
Open access
45%
world 40%
International
44%
world 18%
Mundipharma (United Kingdom)

Which fields of science does Mundipharma (United Kingdom) work in?

In 2022-now, 47% of research at Mundipharma (United Kingdom) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (14%), Agricultural and Biological Sciences (5%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 17 fractional works · 47.1% of its workMedicine: 16 fractional works · 45.0% of its workOncology: 4 fractional works · 10.4% of its workInfectious Diseases: 2 fractional works · 5.8% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.4% of its workEpidemiology: 1 fractional works · 3.5% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 3.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.1% of its workHematology: 1 fractional works · 2.4% of its workGenetics: 1 fractional works · 2.2% of its workPhysiology: 1 fractional works · 1.6% of its workHepatology: 0 fractional works · 1.0% of its workComplementary and alternative medicine: 0 fractional works · 0.9% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workInternal Medicine: 0 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workSurgery: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 1.1% of its workHealth Professions: 1 fractional works · 1.6% of its workEmergency Medical Services: 0 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workLife Sciences: 9 fractional works · 23.6% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 14.2% of its workMolecular Biology: 3 fractional works · 8.2% of its workCancer Research: 1 fractional works · 3.1% of its workBiotechnology: 0 fractional works · 1.4% of its workGenetics: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 2 fractional works · 5.0% of its workPlant Science: 1 fractional works · 2.0% of its workGeneral Agricultural and Biological Sciences: 1 fractional works · 1.9% of its workAnimal Science and Zoology: 0 fractional works · 0.9% of its workInsect Science: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 2.2% of its workImmunology: 1 fractional works · 1.7% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.0% of its workPharmaceutical Science: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 19.9% of its workEngineering: 1 fractional works · 3.5% of its workBiomedical Engineering: 1 fractional works · 1.7% of its workElectrical and Electronic Engineering: 0 fractional works · 1.4% of its workControl and Systems Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 3.2% of its workInformation Systems: 1 fractional works · 2.3% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workComputer Networks and Communications: 0 fractional works · 0.5% of its workChemistry: 1 fractional works · 3.1% of its workOrganic Chemistry: 1 fractional works · 2.8% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 1 fractional works · 2.8% of its workAtmospheric Science: 1 fractional works · 2.8% of its workMaterials Science: 1 fractional works · 2.8% of its workMaterials Chemistry: 1 fractional works · 1.9% of its workBiomaterials: 0 fractional works · 0.9% of its workPhysics and Astronomy: 1 fractional works · 2.8% of its workAstronomy and Astrophysics: 1 fractional works · 2.8% of its workEnvironmental Science: 1 fractional works · 1.6% of its workWater Science and Technology: 0 fractional works · 1.4% of its workEcology: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.2% of its workBioengineering: 0 fractional works · 0.2% of its workSocial Sciences: 3 fractional works · 9.4% of its workSocial Sciences: 1 fractional works · 3.7% of its workSociology and Political Science: 0 fractional works · 1.2% of its workUrban Studies: 0 fractional works · 0.9% of its workPolitical Science and International Relations: 0 fractional works · 0.7% of its workEducation: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.8% of its workEconomics and Econometrics: 1 fractional works · 2.8% of its workArts and Humanities: 0 fractional works · 1.0% of its workHistory: 0 fractional works · 0.6% of its workArcheology: 0 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.9% of its workClinical Psychology: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.6% of its workInformation Systems and Management: 0 fractional works · 0.4% of its workManagement Science and Operations Research: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.3% of its workALL ITS WORKMundipharma(United Kingdom)36fractional works, 2022-now
Life Sciences24%Physical Sciences20%Health Sciences47%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine1645.0%
    2. Health Professions11.6%
    3. Veterinary00.4%
    1. Biochemistry, Genetics and Molecular Biology514.2%
    2. Agricultural and Biological Sciences25.0%
    3. Immunology and Microbiology12.2%
    4. Pharmacology, Toxicology and Pharmaceutics12.0%
    5. Neuroscience00.2%
    1. Engineering13.5%
    2. Computer Science13.2%
    3. Chemistry13.1%
    4. Earth and Planetary Sciences12.8%
    5. Materials Science12.8%
    6. Physics and Astronomy12.8%
    7. Environmental Science11.6%
    8. Chemical Engineering00.2%
    1. Social Sciences13.7%
    2. Economics, Econometrics and Finance12.8%
    3. Arts and Humanities01.0%
    4. Psychology00.9%
    5. Decision Sciences00.6%
    6. Business, Management and Accounting00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.05× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.67× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 2.19× its world share, 1 worksImmunology and Micro…Neuroscience: 0.11× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.69× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.66× its world share, 0 worksChemical EngineeringChemistry: 1.95× its world share, 1 worksChemistryComputer Science: 0.42× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 1.77× its world share, 1 worksEarth and Planetary …Engineering: 0.23× its world share, 1 worksEngineeringEnvironmental Science: 0.33× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.80× its world share, 1 worksMaterials SciencePhysics and Astronomy: 1.25× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.61× its world share, 1 worksHealth ProfessionsMedicine: 2.34× its world share, 16 worksMedicineVeterinary: 3.35× its world share, 0 worksVeterinaryArts and Humanities: 0.35× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.10× its world share, 0 worksBusiness, Management…Decision Sciences: 0.60× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.30× its world share, 1 worksEconomics, Econometr…Psychology: 0.31× its world share, 0 worksPsychologySocial Sciences: 0.29× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.7×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.69×1 works
  2. Veterinary3.35×0 works
  3. Biochemistry, Genetics and Molecular Biology2.67×5 works
  4. Medicine2.34×16 works
  5. Immunology and Microbiology2.19×1 works
  6. Chemistry1.95×1 works
  7. Earth and Planetary Sciences1.77×1 works
  8. Economics, Econometrics and Finance1.30×1 works
  9. Physics and Astronomy1.25×1 works
  10. Agricultural and Biological Sciences1.05×2 works
  11. Materials Science0.80×1 works
  12. Chemical Engineering0.66×0 works
  13. Health Professions0.61×1 works
  14. Decision Sciences0.60×0 works
  15. Computer Science0.42×1 works
  16. Arts and Humanities0.35×0 works
  17. Environmental Science0.33×1 works
  18. Psychology0.31×0 works
  19. Social Sciences0.29×1 works
  20. Engineering0.23×1 works
  21. Neuroscience0.11×0 works
  22. Business, Management and Accounting0.10×0 works

Who are the top researchers at Mundipharma (United Kingdom)?

Ranked on the quality score, Andrew Xia, Kevin J. Smith and Mark Lomax lead among researchers whose main affiliation is Mundipharma (United Kingdom).

  1. 1 Andrew Xia United Kingdom · #1,438,791 worldwide 144 citations · 35 works
  2. 2 Kevin J. Smith United Kingdom · #1,478,590 worldwide 1.5k citations · 44 works
  3. 3 Mark Lomax United Kingdom · #2,046,316 worldwide 529 citations · 46 works
  4. 4 Gill Mundin United Kingdom · #2,205,852 worldwide 471 citations · 24 works
  5. 5 Sara Dickerson United Kingdom · #2,345,605 worldwide 550 citations · 29 works
  6. 6 Andrzej Dymek United Kingdom · #2,492,471 worldwide 508 citations · 18 works
  7. 7 James Kenworthy United Kingdom · #2,659,466 worldwide 742 citations · 21 works
  8. 8 Tammy McIver United Kingdom · #3,113,640 worldwide 482 citations · 50 works
  9. 9 Nick Manamley United Kingdom · #3,165,436 worldwide 249 citations · 34 works
  10. 10 Thomas Mehrling United Kingdom · #3,238,572 worldwide 445 citations · 40 works
All ranked researchers at Mundipharma (United Kingdom)

What are the most cited papers from Mundipharma (United Kingdom)?

The most cited paper from Mundipharma (United Kingdom) is "Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment" (Harald Breivik, Beverly Collett, Vittorio Ventafridda et al., 2005), with 5,568 citations. Next come "How many drug targets are there?" (3,554) and "The Human Plasma Proteome" (1,013).

Most cited papers
#PaperReleasedCitations
1 Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment Harald Breivik, Beverly Collett, Vittorio Ventafridda et al. · European Journal of Pain Open access 11 Aug 2005 5,568
2 How many drug targets are there? John P. Overington, Bissan Al‐Lazikani, Andrew L. Hopkins · Nature Reviews Drug Discovery Review Dec 2006 3,554
3 The Human Plasma Proteome N. Leigh Anderson, Malu Polanski, Rembert Pieper et al. · Molecular & Cellular Proteomics Open access 12 Jan 2004 1,013
4 Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes Harald Breivik, Nathan I. Cherny, Brent R. Collett et al. · Annals of Oncology Open access 24 Feb 2009 805
5 Can we rationally design promiscuous drugs? Andrew L. Hopkins, John O. Mason, John P. Overington · Current Opinion in Structural Biology 27 Jan 2006 472
All 60 most cited papers, with filters and sorting

Which keywords describe research at Mundipharma (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Antifungal Therapy, Immunocompromised Patients, Breast Cancer, Tumor Microenvironment, Candidiasis, Invasive Fungal Infections and Gene Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology4▲ 2.6×17 topics
  2. Antifungal Therapy2▲ 64×3 topics
  3. Inflammation2▲ 2.6×10 topics
  4. Breast Cancer2▲ 19×3 topics
  5. Climate Change2▲ 1.78×3 topics
  6. Immunocompromised Patients2▲ 85×2 topics
  7. Immunotherapy2▲ 6.4×6 topics
  8. Tumor Microenvironment2▲ 10×3 topics
  9. Candidiasis2▲ 100×1 topic
  10. Invasive Fungal Infections2▲ 123×1 topic
  11. Gene Therapy2▲ 22×4 topics
  12. Synthesis2▲ 11×3 topics
  13. Chemotherapy1▲ 5.4×2 topics
  14. Diagnosis1▲ 4.0×8 topics
  15. Monoclonal Antibody1▲ 72×2 topics
  16. Tumor Regression1▲ 35×2 topics
  17. HER21▲ 116×1 topic
  18. Healthcare1▲ 3.0×4 topics
  19. Medicinal Chemistry1▲ 14×2 topics
  20. Monoclonal Antibodies1▲ 42×3 topics
  21. Trastuzumab1▲ 74×1 topic
  22. Treatment1▲ 3.0×9 topics
  23. Wireless Sensor Networks1▲ 8.3×2 topics
  24. Cancer1▲ 2.5×6 topics
  25. Entrepreneurship1▲ 8.2×2 topics
  26. HIF-11▲ 51×1 topic
  27. Intellectual Property1▲ 26×2 topics
  28. Lymphoma1▲ 19×3 topics
  29. Warburg Effect1▲ 51×1 topic
  30. Antimicrobial Activity1▲ 17×1 topic
  31. Astrobiology1▲ 88×1 topic
  32. Capacity Building1▲ 47×2 topics
  33. Cost-effectiveness Analysis1▲ 35×1 topic
  34. Extraterrestrial Life1▲ 128×1 topic
  35. Glacier1▲ 64×1 topic
  36. Global Collaboration1▲ 82×1 topic
  37. Health Biotechnology1▲ 184×1 topic
  38. Health Utility Measures1▲ 35×1 topic
  39. Quinoxaline1▲ 146×1 topic
  40. Water Availability1▲ 64×1 topic

Which research topics does Mundipharma (United Kingdom) publish most on?

By volume in 2022-now: Antifungal resistance and susceptibility, HER2/EGFR in Cancer Research, Cancer, Hypoxia, and Metabolism and Biotechnology and Related Fields.

Antifungal resistance an…2Antifungal resistance and susceptibility: 2 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksBiotechnology and Related Fields: 1 fractional worksSpace Science and Extraterrestrial Life: 1 fractional worksSynthesis and Biological Evaluation: 1 fractional worksCryospheric studies and observations: 1 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksCAR-T cell therapy research: 1 fractional worksRNA Interference and Gene Delivery: 1 fractional works
Infectious DiseasesOncologyCancer ResearchPublic Health, Environmental and Occupational Health5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antifungal resistance and susceptibility Infectious Diseases 2 works
  2. 2 HER2/EGFR in Cancer Research Oncology 1 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  4. 4 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  5. 5 Space Science and Extraterrestrial Life Astronomy and Astrophysics 1 works
  6. 6 Synthesis and Biological Evaluation Organic Chemistry 1 works
  7. 7 Cryospheric studies and observations Atmospheric Science 1 works
  8. 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  9. 9 CAR-T cell therapy research Oncology 1 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.6%not open55.4%

World: 40% of research is openly available.

with international co-authors44.1%domestic only55.9%

World: 18% is written across borders.

How has Mundipharma (United Kingdom)'s research output changed?

Output in 2022-2025 was 0% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mundipharma (United Kingdom) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00020%0.00040%0.00060%Mundipharma (United Kingdom)0.00022% in 202519801990200020102020

Fractional works of Mundipharma (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Share Mundipharma (United Kingdom)'s ranking

Mundipharma (United Kingdom) on Science Explorer

A card with Mundipharma (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Mundipharma (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.